96 related articles for article (PubMed ID: 10472553)
1. Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and -97 protocol.
Mauz-Körholz C; Nürnberger W; Irsfeld H; Körholz D; Göbel U
Klin Padiatr; 1999; 211(4):215-7. PubMed ID: 10472553
[TBL] [Abstract][Full Text] [Related]
2. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
[TBL] [Abstract][Full Text] [Related]
3. [Thrombosis in children with acute lymphoblastic leukemia treated with the COALL protocol].
Eckhof-Donovan S; Schwamborn D; Körholz D; Michelmann I; von Kries R; Nürnberger W; Göbel U
Klin Padiatr; 1994; 206(4):327-30. PubMed ID: 7967433
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis and acute lymphoblastic leukaemia.
Payne JH; Vora AJ
Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
[TBL] [Abstract][Full Text] [Related]
6. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for venous thromboembolism in children.
Gerotziafas GT
Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
[TBL] [Abstract][Full Text] [Related]
8. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.
Wermes C; von Depka Prondzinski M; Lichtinghagen R; Barthels M; Welte K; Sykora KW
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S143-6. PubMed ID: 10650855
[TBL] [Abstract][Full Text] [Related]
10. [In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97].
Janka-Schaub GE; Harms DO; den Boer ML; Veerman AJ; Pieters R
Klin Padiatr; 1999; 211(4):233-8. PubMed ID: 10472556
[TBL] [Abstract][Full Text] [Related]
11. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
Sutor AH; Mall V; Thomas KB
Klin Padiatr; 1999; 211(4):201-4. PubMed ID: 10472550
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of thromboembolic complications in children treated for acute lymphoblastic leukemia with Vascuport catheters].
Rycaj J; Misiołek H; Stoksik P; Tomaszewska R; Karpe J; Kaczmarski J; Kucia H; Knapik P; Kasza T
Wiad Lek; 2005; 58(1-2):41-6. PubMed ID: 15991552
[TBL] [Abstract][Full Text] [Related]
14. Coagulation and fibrinolysis in children with acute lymphoblastic leukaemia treated according to the COALL-05-92-protocol.
Kirschke R; Nürnberger W; Eckhof-Donovan S; Nürnberger I; Göbel U
Klin Padiatr; 1998; 210(4):285-90. PubMed ID: 9743967
[TBL] [Abstract][Full Text] [Related]
15. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
16. Thrombophilia and cancer.
Horowitz N; Brenner B
Pathophysiol Haemost Thromb; 2008; 36(3-4):131-6. PubMed ID: 19176986
[TBL] [Abstract][Full Text] [Related]
17. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
[TBL] [Abstract][Full Text] [Related]
18. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
Santoro N; Colombini A; Silvestri D; Grassi M; Giordano P; Parasole R; Barisone E; Caruso R; Conter V; Valsecchi MG; Masera G; Rizzari C
J Pediatr Hematol Oncol; 2013 Jul; 35(5):348-55. PubMed ID: 23619106
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic therapy with enoxaparin in children with acute lymphoblastic leukemia and inherited thrombophilia during L-asparaginase treatment.
Harlev D; Zaidman I; Sarig G; Ben Arush MW; Brenner B; Elhasid R
Thromb Res; 2010 Aug; 126(2):93-7. PubMed ID: 20546854
[TBL] [Abstract][Full Text] [Related]
20. Significant association with location of central venous line placement and risk of venous thrombosis in children.
Male C; Julian JA; Massicotte P; Gent M; Mitchell L;
Thromb Haemost; 2005 Sep; 94(3):516-21. PubMed ID: 16268465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
